Saved in:
Bibliographic Details
Main Authors: Lin, Junjie, Li, Wei, Liu, Yang, Yang, Furui, Liang, Liang, Zeng, Youran, Li, Yihong, Xue, Zheyong, French, Christopher E, Guo, Juan, Cui, Beimi, Liang, Zongsuo, Yang, Dongfeng
Format: Artículo científico
Language:en
Published: Plant communications 2026
Subjects:
Online Access:https://pubmed.ncbi.nlm.nih.gov/41858113/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266071850483713
author Lin, Junjie
Li, Wei
Liu, Yang
Yang, Furui
Liang, Liang
Zeng, Youran
Li, Yihong
Xue, Zheyong
French, Christopher E
Guo, Juan
Cui, Beimi
Liang, Zongsuo
Yang, Dongfeng
author_facet Lin, Junjie
Li, Wei
Liu, Yang
Yang, Furui
Liang, Liang
Zeng, Youran
Li, Yihong
Xue, Zheyong
French, Christopher E
Guo, Juan
Cui, Beimi
Liang, Zongsuo
Yang, Dongfeng
Lin, Junjie
Li, Wei
Liu, Yang
Yang, Furui
Liang, Liang
Zeng, Youran
Li, Yihong
Xue, Zheyong
French, Christopher E
Guo, Juan
Cui, Beimi
Liang, Zongsuo
Yang, Dongfeng
collection PubMed - marine biology
contents Engineering Salvia miltiorrhiza hairy roots as a scalable platform for high-yield production of paclitaxel and ginsenoside precursors. Lin, Junjie Li, Wei Liu, Yang Yang, Furui Liang, Liang Zeng, Youran Li, Yihong Xue, Zheyong French, Christopher E Guo, Juan Cui, Beimi Liang, Zongsuo Yang, Dongfeng Plant Roots Paclitaxel Salvia miltiorrhiza Ginsenosides Diterpenes Panax notoginseng Metabolic Engineering Taxus Sapogenins Alkenes Plants, Genetically Modified Isomerases Plant-derived natural products offer a rich source of therapeutic agents. However, sustainable and high-yield production remains a grand challenge. We engineered Salvia miltiorrhiza hairy roots to produce taxadiene, a key precursor for the anticancer drug paclitaxel, and protopanaxadiol, a precursor for ginsenosides. The heterologous expression of two key biosynthetic genes, taxadiene synthase from Taxus wallichiana and protopanaxadiol synthase from Panax notoginseng, enabled the production of taxadiene and protopanaxadiol, respectively. Our strategy combined multiple approaches to enhance terpenoid production, including genome editing to redirect metabolic flux by eliminating a competing GGPP sink (via SmCPS1 disruption), transcriptional reprogramming through SmWRKY61 overexpression to enhance terpenoid precursor pathways (MVA/MEP), and optimization of cultivation conditions. This holistic approach yielded 65.17 ± 5.25 mg/kg fresh weight (FW) taxadiene in batch cultures, and the protopanaxadiol yield reached 50.04 ± 2.94 mg/kg dry weight (DW) without optimization. These results highlight the potential of this platform for industrial-scale production. Our findings demonstrate that S. miltiorrhiza hairy roots can serve as a robust and scalable platform to produce valuable plant-derived compounds. This work paves the way for future metabolic engineering efforts to achieve cost-effective and sustainable production of high-value natural products using medicinal plant systems, addressing critical supply bottlenecks for pharmaceutical compounds.
format Artículo científico
id pubmed_41858113
institution PubMed
language en
publishDate 2026
publisher Plant communications
record_format pubmed
spellingShingle Engineering Salvia miltiorrhiza hairy roots as a scalable platform for high-yield production of paclitaxel and ginsenoside precursors.
Lin, Junjie
Li, Wei
Liu, Yang
Yang, Furui
Liang, Liang
Zeng, Youran
Li, Yihong
Xue, Zheyong
French, Christopher E
Guo, Juan
Cui, Beimi
Liang, Zongsuo
Yang, Dongfeng
Plant Roots
Paclitaxel
Salvia miltiorrhiza
Ginsenosides
Diterpenes
Panax notoginseng
Metabolic Engineering
Taxus
Sapogenins
Alkenes
Plants, Genetically Modified
Isomerases
Engineering Salvia miltiorrhiza hairy roots as a scalable platform for high-yield production of paclitaxel and ginsenoside precursors. Lin, Junjie Li, Wei Liu, Yang Yang, Furui Liang, Liang Zeng, Youran Li, Yihong Xue, Zheyong French, Christopher E Guo, Juan Cui, Beimi Liang, Zongsuo Yang, Dongfeng Plant Roots Paclitaxel Salvia miltiorrhiza Ginsenosides Diterpenes Panax notoginseng Metabolic Engineering Taxus Sapogenins Alkenes Plants, Genetically Modified Isomerases Plant-derived natural products offer a rich source of therapeutic agents. However, sustainable and high-yield production remains a grand challenge. We engineered Salvia miltiorrhiza hairy roots to produce taxadiene, a key precursor for the anticancer drug paclitaxel, and protopanaxadiol, a precursor for ginsenosides. The heterologous expression of two key biosynthetic genes, taxadiene synthase from Taxus wallichiana and protopanaxadiol synthase from Panax notoginseng, enabled the production of taxadiene and protopanaxadiol, respectively. Our strategy combined multiple approaches to enhance terpenoid production, including genome editing to redirect metabolic flux by eliminating a competing GGPP sink (via SmCPS1 disruption), transcriptional reprogramming through SmWRKY61 overexpression to enhance terpenoid precursor pathways (MVA/MEP), and optimization of cultivation conditions. This holistic approach yielded 65.17 ± 5.25 mg/kg fresh weight (FW) taxadiene in batch cultures, and the protopanaxadiol yield reached 50.04 ± 2.94 mg/kg dry weight (DW) without optimization. These results highlight the potential of this platform for industrial-scale production. Our findings demonstrate that S. miltiorrhiza hairy roots can serve as a robust and scalable platform to produce valuable plant-derived compounds. This work paves the way for future metabolic engineering efforts to achieve cost-effective and sustainable production of high-value natural products using medicinal plant systems, addressing critical supply bottlenecks for pharmaceutical compounds.
title Engineering Salvia miltiorrhiza hairy roots as a scalable platform for high-yield production of paclitaxel and ginsenoside precursors.
topic Plant Roots
Paclitaxel
Salvia miltiorrhiza
Ginsenosides
Diterpenes
Panax notoginseng
Metabolic Engineering
Taxus
Sapogenins
Alkenes
Plants, Genetically Modified
Isomerases
url https://pubmed.ncbi.nlm.nih.gov/41858113/